Opportunity BasketEvidence Synthesis Operations Service (ESOS)
A specialized contract research team embedded part-time within pharma R&D departments (or available on-demand) that translates raw datasets into validated evidence packages using a proprietary evidence-chain methodology. The team maps data lineage, validates relationships across sources, flags missing context, and produces clinical-grade evidence summaries with audit trails—cutting synthesis time from months to weeks.
46 weeks • 70% confidence
Value Proposition
Removes the 60–70% of drug development delay caused by evidence synthesis bottlenecks, not data volume. Provides regulatory-ready audit trails and context preservation that off-the-shelf tools cannot. Costs 40% less than hiring permanent FTE evidence managers.
Target Audience
Mid-to-large pharma companies (Phase II/III trials, 500+ researchers) and biotech firms with 50+ FTE R&D teams running parallel studies
Key Features
- On-site or embedded evidence synthesis team (2–4 senior analysts per client)
- Evidence-chain mapping: documents every transformation from raw data → insight with human validation checkpoints
- Cross-source relationship validation: flags contradictions, missing context, and causality gaps before they derail decisions
- And more, with full implementation detail...
Tech Stack
Unlock the full solution
You're seeing a preview. Unlock the complete value proposition, every feature, the full tech stack, the monetization model, and the week-by-week build roadmap, plus a downloadable PDF.
Sign up free to continue3 free solution credits on signup
The build plan is behind the wall
Subscribers get the full monetization model, pricing strategy, and the complete week-by-week roadmap to build this.
Sign up freeOriginal Problem
Pharmaceutical researchers cannot convert raw data into clinically valid evidence fast enough for drug development timelinesDrug development teams are drowning in data but lack the tools and processes to extract meaningful evidence from it—losing months or years translating datasets into actionable insights. Researchers struggle to preserve context, relationships, and meaning across disparate data sources, causing delays in critical decision-making and slowing time-to-market for life-saving drugs. Existing data management solutions treat this as a volume problem when the real bottleneck is evidence synthesis and validation.
Score: 50.6% • 1 demand signal